CIK 0001662579 · Non-accelerated filer<br>Smaller reporting company
C4 Therapeutics, Inc.
Sign in to watch- Ticker
- CCCC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475617627
- Phone
- (617) 231-0700
- Business address
- 490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-10-28 | Mahaney Paige Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +345,600 | 345,600 | ||
| 2024-10-01 | GROGAN DONNA ROY Director | Grant or award | +2,474 | $5.56 | $14K | 28,942 |
| 2024-10-01 | Anderson Kenneth Carl Director | Grant or award | +2,023 | $5.56 | $11K | 116,694 |
| 2024-09-18 | Adams Kendra Chief Financial Officer | Shares withheld for taxes | −1,837 | $6.38 | $12K | 81,791 |
| 2024-09-16 | Hirsch Andrew President & CEO | Option exercise | +7,500 | 218,241 | ||
| 2024-09-16 | Hirsch Andrew President & CEO | Shares withheld for taxes | −3,329 | $6.36 | $21K | 214,912 |
| 2024-09-16 | Hirsch Andrew President & CEO | Option exercise · Performance Restricted Stock Units | −7,500 | 47,500 | ||
| 2024-09-16 | Boyle Scott N Chief Business Officer | Option exercise | +2,250 | 54,580 | ||
| 2024-09-16 | Boyle Scott N Chief Business Officer | Shares withheld for taxes | −661 | $6.36 | $4K | 53,919 |
| 2024-09-16 | Boyle Scott N Chief Business Officer | Option exercise · Performance Restricted Stock Units | −2,250 | 14,250 | ||
| 2024-09-16 | Adams Kendra Chief Financial Officer | Option exercise | +2,250 | 84,289 | ||
| 2024-09-16 | Adams Kendra Chief Financial Officer | Shares withheld for taxes | −661 | $6.36 | $4K | 83,628 |
| 2024-09-16 | Adams Kendra Chief Financial Officer | Option exercise · Performance Restricted Stock Units | −2,250 | 14,250 | ||
| 2024-09-16 | Fisher Stewart Chief Scientific Officer | Option exercise | +2,250 | 131,371 | ||
| 2024-09-16 | Fisher Stewart Chief Scientific Officer | Shares withheld for taxes | −661 | $6.36 | $4K | 130,710 |
| 2024-09-16 | Fisher Stewart Chief Scientific Officer | Option exercise · Performance Restricted Stock Units | −2,250 | 14,250 | ||
| 2024-09-16 | Schick Kelly Chief People Officer | Option exercise | +2,250 | 54,501 | ||
| 2024-09-16 | Schick Kelly Chief People Officer | Shares withheld for taxes | −661 | $6.36 | $4K | 53,840 |
| 2024-09-16 | Schick Kelly Chief People Officer | Option exercise · Performance Restricted Stock Units | −2,250 | 14,250 | ||
| 2024-09-16 | Siegel Jolie Chief Legal Officer | Option exercise | +2,250 | 54,501 |
Page 7 of 27 · 525 trades